Oak Thistle LLC purchased a new position in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 11,247 shares of the semiconductor company’s stock, valued at approximately $1,506,000.
Other large investors have also bought and sold shares of the company. IMG Wealth Management Inc. bought a new position in shares of Lam Research in the second quarter worth approximately $26,000. Howard Hughes Medical Institute purchased a new stake in Lam Research during the 2nd quarter valued at $27,000. Strategic Wealth Investment Group LLC bought a new stake in Lam Research in the 2nd quarter worth $29,000. Delos Wealth Advisors LLC purchased a new position in shares of Lam Research in the second quarter valued at about $30,000. Finally, REAP Financial Group LLC purchased a new position in shares of Lam Research in the second quarter valued at about $31,000. 84.61% of the stock is owned by hedge funds and other institutional investors.
Lam Research Stock Down 5.1%
Shares of NASDAQ:LRCX opened at $154.98 on Thursday. The firm has a market capitalization of $194.66 billion, a P/E ratio of 34.14, a P/E/G ratio of 1.68 and a beta of 1.77. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. The stock has a 50 day moving average price of $153.54 and a 200-day moving average price of $121.88. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $169.69.
Lam Research Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be paid a $0.26 dividend. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is presently 22.91%.
Insider Buying and Selling at Lam Research
In other news, insider Ava Harter sold 9,010 shares of the business’s stock in a transaction that occurred on Monday, October 27th. The stock was sold at an average price of $157.47, for a total value of $1,418,804.70. Following the sale, the insider directly owned 56,786 shares of the company’s stock, valued at $8,942,091.42. The trade was a 13.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the sale, the senior vice president owned 251,047 shares in the company, valued at $34,870,428.30. The trade was a 17.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 102,608 shares of company stock valued at $14,916,496. Insiders own 0.31% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research firms have recently weighed in on LRCX. Wall Street Zen lowered shares of Lam Research from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. HSBC set a $127.00 price objective on Lam Research and gave the stock a “hold” rating in a report on Tuesday, September 30th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $210.00 price objective on shares of Lam Research in a research report on Tuesday. JPMorgan Chase & Co. upped their target price on Lam Research from $113.00 to $165.00 and gave the company an “overweight” rating in a report on Thursday, October 23rd. Finally, Citigroup raised their price target on Lam Research from $175.00 to $190.00 and gave the stock a “buy” rating in a research note on Tuesday, November 11th. Twenty-six research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $158.54.
Get Our Latest Stock Report on LRCX
Lam Research Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Featured Articles
- Five stocks we like better than Lam Research
- What is the Shanghai Stock Exchange Composite Index?
- Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock
- What Are Dividends? Buy the Best Dividend Stocks
- Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
